Seroprevalence of IgG antibodies against pertussis toxin in the Chinese population: A systematic review and meta-analysis.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
31 Dec 2024
Historique:
medline: 2 5 2024
pubmed: 2 5 2024
entrez: 2 5 2024
Statut: ppublish

Résumé

Pertussis is a vaccine-preventable infectious disease; however, data on pertussis antibody levels in a nationwide population are still limited in China. We aimed to pool the seropositivity rates of IgG antibodies against pertussis toxin (PT-IgG) across the country. We systematically searched PubMed, Web of Science, Embase, and the China National Knowledge Infrastructure Database for studies published between January 1, 2010, and June 30, 2023. Studies reporting the seroprevalence of PT-IgG among a healthy Chinese population were included. Pooled estimates were obtained using random-effects meta-analyzes. The meta-analysis included 39 studies (47,778 participants) reporting anti-PT IgG seropositivity rates. The pooled rate for all ages was 7.06% (95% CI, 5.50%-9.07%). Subgroup analyzes showed rates ranging from 6.36% to 12.50% across different age groups. This meta-analysis indicated a low anti-PT IgG seropositivity rate in the Chinese population, particularly among school-aged children and young adults. This finding underscores the urgent need to refine immunization strategies.

Identifiants

pubmed: 38695296
doi: 10.1080/21645515.2024.2341454
doi:

Substances chimiques

Pertussis Toxin EC 2.4.2.31
Immunoglobulin G 0
Antibodies, Bacterial 0
Pertussis Vaccine 0

Types de publication

Systematic Review Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2341454

Auteurs

Yao Zhu (Y)

Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.

Wanting Zhang (W)

Jiaxing Center for Disease Control and Prevention, Jiaxing, China.

Jie Hu (J)

Jiaxing Center for Disease Control and Prevention, Jiaxing, China.

Shuying Luo (S)

Department of Immunization Program, Yiwu District Center for Disease Control and Prevention, Yiwu, China.

Yang Zhou (Y)

Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.

Xuewen Tang (X)

Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.

Rui Yan (R)

Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.

Xuan Deng (X)

Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.

Hanqing He (H)

Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH